Print

UICC announces a new global coalition to increase access to and the use of essential cancer medicines in low- and lower middle-income countries (May 2022)

GENEVA, SWITZERLAND / AGILITYPR.NEWS / May 20, 2022 / The Union for International Cancer Control (UICC) and multiple partners* are establishing the Access to Oncology Medicines (ATOM) Coalition, a new global partnership to increase access to quality-assured essential cancer medicines in low- and lower middle-income countries (LLMICs) and to help countries develop the capacity for their proper use.

Print

IGBA’s Newly Launched CEO Advisory Committee Holds Inaugural Meeting with WTO Director General (May 2022)

The newly established IGBA CEO Advisory Committee, a forum for generic and biosimilar medicines industry leaders to discuss broad, strategic issues, and to engage and position the industry on a range of critical policy matters, held its inaugural meeting on Monday, May 2 and launched initial discussions with World Trade Organization (WTO) Director-General Dr. Ngozi Okonjo-Iweala.

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

Telephone: +32 (0)477438729 (S. Kox)
E-mails: 
This email address is being protected from spambots. You need JavaScript enabled to view it.  
or  
Secretary General –   This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site